Publikationen in Zusammenarbeit mit Forschern von University Hospital of Bern (11)

2020

  1. Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial

    Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 5, pp. E516-E526

2018

  1. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    The Lancet, Vol. 392, Núm. 10151, pp. 940-949

2017

  1. Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents

    Journal of the American College of Cardiology, Vol. 70, Núm. 1, pp. 60-74

2016

  1. The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

    EuroIntervention, Vol. 12, Núm. 1, pp. 79-87

2014

  1. Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation

    International Journal of Cardiology, Vol. 177, Núm. 2, pp. 448-454

2013

  1. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: In-hospital results in 4,571 patients

    EuroIntervention, Vol. 8, Núm. 12, pp. 1362-1371

2011

  1. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the resolute all comers trial

    JACC: Cardiovascular Interventions, Vol. 4, Núm. 4, pp. 432-441

2010

  1. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

    New England Journal of Medicine, Vol. 363, Núm. 2, pp. 136-146

2002

  1. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial

    Journal of the American Medical Association, Vol. 287, Núm. 24, pp. 3215-3222

1997

  1. Die TREND-Studie (Trial on Reversing ENdothelial Dysfunction): ACE-Hemmung mit Quinapril verbessert die endotheliale vasomotorische Dysfunktion bei Patienten mit koronarer Herzerkrankung

    Munchener Medizinische Wochenschrift, Vol. 139, Núm. 14, pp. 213-221

1996

  1. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND (Trial on Reversing ENdothelial Dysfunction) study

    Circulation, Vol. 94, Núm. 3, pp. 258-265